{"schema_version":"alpha-profile-public-v1","slug":"geoffrey-dow","canonical_url":"https://registry.alpha.ac/people/geoffrey-dow","as_of":"2026-09-21T14:05:14.644357+00:00","published_at":"2026-09-02T02:37:22.26731+00:00","last_reviewed_at":"2026-05-16T08:54:21.304+00:00","identity":{"display_name":"Geoffrey Dow","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"60 DEGREES PHARMACEUTICALS, INC.","company_slug":"60-degrees-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"SXTPW","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2022-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","effective_date":"2025-08-27","last_checked_at":"2026-04-28T22:50:09.495+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=geoffrey-dow","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=geoffrey-dow&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Over 20 years of product development experience in tropical diseases with 13 years in key leadership roles at Walter Reed Army Institute of Research. Co-founded 60 Degrees Pharmaceuticals in 2010 and led FDA regulatory approval for Tafenoquine (Arakoda) for malaria prophylaxis."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"60 DEGREES PHARMACEUTICALS, INC.","organizationId":"60-degrees-pharmaceuticals-inc","title":"Director","period":"2022-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"60 DEGREES PHARMACEUTICALS, INC.","company_slug":"60-degrees-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"SXTPW","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2022-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","effective_date":"2025-08-27","last_checked_at":"2026-04-28T22:50:09.495+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Geoffrey Dow as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T08:54:21.503131+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","published_at":"2026-03-30T00:00:00+00:00","last_checked_at":"2026-05-16T08:54:21.359195+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Geoffrey Dow as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:52:01.699774+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","published_at":"2025-08-27T00:00:00+00:00","last_checked_at":"2026-05-16T02:52:01.556421+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Geoffrey Dow currently serves as Director at 60 DEGREES PHARMACEUTICALS, INC..","claim_state":"verified","valid_from":"2025-08-27","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:52:01.650463+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","published_at":"2025-08-27T00:00:00+00:00","last_checked_at":"2026-05-16T02:52:01.556421+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Geoffrey Dow serves on no disclosed committees.","claim_state":"verified","valid_from":"2025-08-27","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:52:01.676654+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","published_at":"2025-08-27T00:00:00+00:00","last_checked_at":"2026-05-16T02:52:01.556421+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"60 Degrees Pharmaceuticals, Inc.","claim_text":"Geoffrey Dow is linked to 60 Degrees Pharmaceuticals, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:52:01.839238+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","published_at":"2025-08-27T00:00:00+00:00","last_checked_at":"2026-05-16T02:52:01.556421+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer and President","claim_text":"Geoffrey Dow is also listed as Chief Executive Officer and President.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:52:01.815854+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","published_at":"2025-08-27T00:00:00+00:00","last_checked_at":"2026-05-16T02:52:01.556421+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Geoffrey Dow as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T08:54:21.534659+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","published_at":"2026-03-30T00:00:00+00:00","last_checked_at":"2026-05-16T08:54:21.359195+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Geoffrey Dow as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:52:01.746786+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","published_at":"2025-08-27T00:00:00+00:00","last_checked_at":"2026-05-16T02:52:01.556421+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"60 DEGREES PHARMACEUTICALS, INC.","claim_text":"Geoffrey Dow is associated with 60 DEGREES PHARMACEUTICALS, INC..","claim_state":"verified","valid_from":"2026-03-30","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T08:54:21.484832+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","published_at":"2026-03-30T00:00:00+00:00","last_checked_at":"2026-05-16T08:54:21.359195+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Chief Executive Officer, President and Director","claim_text":"Geoffrey Dow is listed as Chief Executive Officer, President and Director at 60 DEGREES PHARMACEUTICALS, INC..","claim_state":"verified","valid_from":"2026-03-30","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T08:54:21.465009+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","published_at":"2026-03-30T00:00:00+00:00","last_checked_at":"2026-05-16T08:54:21.359195+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Executive extraction classified technology background for Geoffrey Dow as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T08:54:21.518224+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","published_at":"2026-03-30T00:00:00+00:00","last_checked_at":"2026-05-16T08:54:21.359195+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Geoffrey Dow as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:52:01.722872+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"SXTP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","published_at":"2025-08-27T00:00:00+00:00","last_checked_at":"2026-05-16T02:52:01.556421+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:geoffrey-dow","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2022-01-01 · current","organization":"60 DEGREES PHARMACEUTICALS, INC.","organization_id":"60-degrees-pharmaceuticals-inc"},"claim_text":"Director at 60 DEGREES PHARMACEUTICALS, INC. (2022-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/geoffrey-dow#profile","url":"https://registry.alpha.ac/people/geoffrey-dow","dateModified":"2026-05-16T08:54:21.304+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/geoffrey-dow#person","name":"Geoffrey Dow","url":"https://registry.alpha.ac/people/geoffrey-dow","jobTitle":"Director","worksFor":{"@type":"Organization","name":"60 DEGREES PHARMACEUTICALS, INC.","tickerSymbol":"NASDAQ: SXTPW"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","memberOf":{"@type":"Organization","name":"60 DEGREES PHARMACEUTICALS, INC.","url":"https://registry.alpha.ac/companies/60-degrees-pharmaceuticals-inc","tickerSymbol":"NASDAQ: SXTPW"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","name":"SXTP 10-K executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","name":"SXTP DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/geoffrey-dow"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":6,"corroborated":4,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":10,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":6,"corroborated":4,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":10,"corroborated_claims":4,"sources":4,"distinct_sources":2,"role_claims":1,"last_reviewed_at":"2026-05-16T08:54:21.304+00:00","observed_at":"2026-09-21T14:05:14.644357+00:00","freshness_days":128}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"geoffrey-dow","canonical_url":"https://registry.alpha.ac/people/geoffrey-dow"},"publication":{"published_at":"2026-09-02T02:37:22.26731+00:00","last_reviewed_at":"2026-05-16T08:54:21.304+00:00","as_of":"2026-09-21T14:05:14.644357+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/geoffrey-dow","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/geoffrey-dow","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/geoffrey-dow.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}